H.PIO Co., Ltd. (KOSDAQ:357230)
2,470.00
+10.00 (0.41%)
At close: Jan 23, 2026
H.PIO Revenue
H.PIO had revenue of 64.34B KRW in the quarter ending September 30, 2025, with 9.28% growth. This brings the company's revenue in the last twelve months to 257.56B, up 7.97% year-over-year. In the year 2024, H.PIO had annual revenue of 242.83B with 4.66% growth.
Revenue (ttm)
257.56B
Revenue Growth
+7.97%
P/S Ratio
0.40
Revenue / Employee
3.39B
Employees
76
Market Cap
101.95B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 242.83B | 10.80B | 4.66% |
| Dec 31, 2023 | 232.03B | 36.05B | 18.39% |
| Dec 31, 2022 | 195.98B | 36.54B | 22.92% |
| Dec 31, 2021 | 159.43B | 16.65B | 11.66% |
| Dec 31, 2020 | 142.79B | 84.18B | 143.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ahn-Gook Pharmaceutical | 300.96B |
| Daehan Nupharm | 201.59B |
| HYUNDAI BIOLAND | 129.68B |
| Sinsin Pharmaceutical | 110.29B |
| Hwail Pharmaceutical | 107.87B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 102.11B |
| Sam-A Pharm. | 76.66B |
| High Tech Pharm | 75.60B |